Dexcom (DXCM)
NASDAQ:DXCM
Holding DXCM?
Track your performance easily

Dexcom (DXCM) Financial Statements

3,813 Followers

Dexcom Financial Overview

Dexcom's market cap is currently ―. The company's EPS TTM is $1.668; its P/E ratio is 41.31; Dexcom is scheduled to report earnings on February 6, 2025, and the estimated EPS forecast is $0.52. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Dec 23Sep 23
Income Statement-
Total Revenue$ 994.20M$ 1.00B$ 921.00M$ 1.03B$ 975.00M
Gross Profit$ 593.80M$ 626.70M$ 561.90M$ 656.60M$ 623.30M
EBIT$ 181.10M$ 191.60M$ 137.10M$ 251.10M$ 244.20M
EBITDA$ 236.40M$ 243.70M$ 189.60M$ 303.60M$ 292.40M
Net Income Common Stockholders$ 134.60M$ 143.50M$ 146.40M$ 256.30M$ 120.70M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 621.20M$ 939.20M$ 851.20M$ 566.30M$ 643.70M
Total Assets$ 6.35B$ 6.80B$ 6.48B$ 6.26B$ 6.60B
Total Debt$ 2.53B$ 2.54B$ 2.53B$ 2.54B$ 2.66B
Net Debt$ 1.91B$ 1.60B$ 1.68B$ 1.97B$ 2.02B
Total Liabilities$ 4.37B$ 4.36B$ 4.24B$ 4.20B$ 4.33B
Stockholders Equity$ 1.98B$ 2.43B$ 2.25B$ 2.07B$ 2.27B
Cash Flow-
Free Cash Flow$ 88.30M$ 213.30M$ 152.30M$ 81.10M$ 218.80M
Operating Cash Flow$ 199.50M$ 279.40M$ 209.20M$ 133.60M$ 269.20M
Investing Cash Flow$ 210.30M$ -188.90M$ 74.80M$ 414.90M$ -179.50M
Financing Cash Flow$ -736.50M$ -1.40M$ 4.70M$ -631.90M$ -637.40M
Currency in USD

Dexcom Earnings and Revenue History

Dexcom Debt to Assets

Dexcom Cash Flow

Dexcom Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis